Advertisement
Patient-patient network analysis proves to be fast and clinically intuitive
Three C Study suggests 28-day efficacy window, 600-mg dose
Despite its longevity, this foundational operation keeps getting refined
An ACC committee issues recommendations to accelerate sluggish progress
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Snapshots from the nation’s busiest noninvasive vascular laboratory
Nearly three-quarters found lacking in methodological quality and/or reporting practices
Researchers urge caution when managing AAA in this population
Recurrence and outcomes for stage II disease are worse than in ever-smokers
A staged hybrid strategy respects the chronic nature of thoracic aortic disease
Advancements are expanding applications and improving accuracy and patient experience
Advertisement
Advertisement